Alitair Pharmaceuticals' Unattributed - II Round

Alitair Pharmaceuticals raised a round of funding on March 10, 2017.

Alitair is a specialty pharmaceutical company with a focus on the respiratory space. The company is developing two Orphan drugs for bronchiectasis.…

Articles about Alitair Pharmaceuticals' Unattributed - II Round: